stockrowWaystar Holding Corp.
WAY Healthcare Health Information Services
Waystar Holding Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.1 billion, up 16.5% from fiscal 2024.
- Revenue
- +21.2%
- EPS
- −10.2%
- Free cash flow
- +23.4%
- Total debt
- +18.4%
Quarter to September 2026, against a year earlier
Follow WAY
Alert me
Waystar Holding Corp. (WAY) EV/EBITDA
As of 5 November 2026, Waystar Holding Corp. (WAY) trades at a EV/EBITDA of 15.0×. Over the past ten years it has ranged from 0.0× (June 2024) to 25.4× (December 2024); the current reading is higher than 32% of that period. That is above the Health Information Services industry median of 13.4× and above the Healthcare sector median of 8.4×.
EV/EBITDA, daily
Embed this chart
Annual newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| FY2025 | 18.3× | (11.89%) |
| FY2024 | 20.8× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
Quarterly newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| Sep 2026 | 13.6× | 13.90% |
| Jun 2026 | 11.9× | (16.11%) |
| Mar 2026 | 14.2× | (22.59%) |
| Dec 2025 | 18.3× | (4.83%) |
| 9 more quarters | Free account |
Against its own ten years
EV/EBITDA against peers
| Company | EV/EBITDA |
|---|---|
| TEM Tempus AI, Inc. compare | n/m |
| HTFL Heartflow, Inc. compare | n/m |
| SDGR Schrodinger, Inc. compare | n/m |
| WAY Waystar Holding Corp. | 15.0× |
| HQY HealthEquity, Inc. compare | 18.2× |
| BTSG BrightSpring Health Services, Inc. compare | 21.9× |
| DOCS Doximity, Inc. compare | 24.0× |
| PRVA Privia Health Group, Inc. compare | 41.1× |
| HNGE Hinge Health Inc. compare | 54.5× |
| Health Information Services industry median | 13.4× |
| Healthcare sector median | 8.4× |
| Market median | 10.9× |
What EV/EBITDA is
Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)
More on WAY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Beneish M-score
- The full statement